Dynavax to Host First Quarter 2018 Financial Results Conference Call
May 02 2018 - 4:15PM
Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that
it will report financial results for the first quarter ended March
31, 2018 after market close on Tuesday, May 8, 2018, and host a
conference call that day to review the results and provide a
business update at 4:30pm ET/1:30pm PT.
To access the call, participants must dial (866) 548-4713 in the
U.S. or (323) 794-2093 internationally, and use the conference ID
8635193. The live call will be webcast and can be accessed in the
"Investors and Media" section of the company's website at
www.dynavax.com. A replay of the webcast will be available for 30
days following the live event.
A replay of the conference call will be available for two weeks
and can be accessed by dialing (844) 512-2921 in the U.S. or (412)
317-6671 internationally. The conference ID for the replay will be
8635193.
About DynavaxDynavax is a fully-integrated
biopharmaceutical company focused on leveraging the power of the
body's innate and adaptive immune responses through toll-like
receptor (TLR) stimulation. Dynavax discovers and develops novel
vaccines and immuno-oncology therapeutics. The Company’s first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], is approved in the United States. Dynavax's lead
immunotherapy product, SD-101, is an investigational cancer
immunotherapeutic currently being evaluated in Phase 1/2 studies
and its second cancer immunotherapeutic, DV281, is in Phase 1
development. For more information, visit www.dynavax.com.
Contact: David BurkeDirector, IR &
Corporate Communications510.665.7269dburke@dynavax.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024